Abstract
302 Using the 21-gene Breast Cancer Assay in Adjuvant Decision-making in ER-positive (ER+) Early Breast Cancer (EBC) is Cost-effective: Results of a Large Prospective German Multicenter Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have